STAG2 and colorectal adenocarcinoma: Moreover, in xenografts of DLD‐1 colorectal adenocarcinoma cells transduced with sgRNAs targeting STAG2 or control (non‐targeted sgRNA), knockout of STAG2 significantly inhibited tumor growth with ATMi treatment, as measured by tumor volume or tumor mass (Figure 1J–L).